蒲公英 - 制药技术的传播者 GMP理论的实践者

搜索
查看: 914|回复: 3
收起左侧

[质量信息化] 【FDA警告信】加拿大Les Produits Chimiques B.G.R.

[复制链接]
药士
发表于 2018-8-15 10:11:57 | 显示全部楼层 |阅读模式

欢迎您注册蒲公英

您需要 登录 才可以下载或查看,没有帐号?立即注册

x
近期,FDA发布了关于加拿大Les Produits Chimiques B.G.R.的警告信(Warning Letter WL 320-18-64),FDA于2017年9月25-27日对其生产场所进行了检查,发现其原料药生产存在严重违反CGMP的行为。

检查缺陷如下:

1.      Failure to perform laboratory testing of API to ensure conformance to specifications and to accurately report results on certificates of analysis (COA).未能执行API检测以确保其符合质量标准并在COA上准确报告结果。

Your firm distributed multiple lots of (b)(4) powderUSP API without completing required release testing for identity. Your COA reported that these drugs met all required specifications. We reviewed your firm’s COA and laboratory notebooks for (b)(4) powder USP lot #(b)(4), as well as for multiple lots of this product dating back to at least 2015. The laboratory notebooks lacked the analytical data to support the information on your COA. Your firm confirmed to our investigator that, although your COA states that the identity tests “Passed,” you did not perform the tests. Although you never performed the required testing, you distributed these API lots to the U.S. market with false information on the COA.
你们公司销售了多批次XX的USP级别API粉,但并未完成所需的放行检测中的鉴别。你们的COA报告说这些药品符合所有需要的质量标准。我们审核了你们公司的USP级XX API粉的COA和化验室记录,以及多个早到2015年的该产品多个批次。该化验室笔记本缺乏分析数据来支持你们COA上的信息。你们公司向我们的调查人员确认,虽然你们的COA声称鉴别检测为“通过”,但你们并未执行该检测。尽管你们从未执行所要求的检测,但你们依据COA上这些虚假信息将这些批次API都销往了美国市场。

In your response, you provided the identity test results for lots produced since 2015; you conducted these retrospective analyses only after our inspection identified that you had never performed the tests in the first place. Your response is inadequate. While you tested lots identified during our inspection that were manufactured since 2015, you did not test all distributed lots within expiry. In addition, you did not conduct a thorough review of all release records to determine whether the test results for other drug quality attributes were falsely reported.
在你们的回复中,你们提交了自2015年以来生产的批次的鉴别检测结果,你们只是在我们检查过程发现你们刚开始并未执行过检测后才执行的回顾性检测。你们的回复是不充分的。虽然你们检测在我们检查过程中所识别出的批次,但你们并未检测所有已销售而仍在效期的批次。另外,你们亦未对所有放行记录进行审核以确定是否有其它药物质量属性检测结果被错误报告。

Customers and regulators rely on certificates of analysis for critical information about the quality and source of their ingredients.Unreliable information on a COA compromises supply-chain accountability andquality assurance, and may put consumers at risk.
客户和监管人员依赖于COA获得药品成分的质量和来源关键信息。COA上不可靠的信息使得供应链不可靠,使得质量无法确保,同时亦让消费者置身风险中。

2.      Failure of your quality unit to exercise its responsibility to ensure the API manufactured at your facility are in compliance with CGMP.你们质量部门未能履行其确保你们场所生产的API符合CGMP要求的职责。

Your quality unit failed to perform a number of critical functions to ensure that the (b)(4) powder USP API was manufactured according to CGMP. For example, your quality unit failed to ensure that the records it reviewed included complete data derived from all tests conducted to ensure compliance with established specifications and standards prior to the distribution of an API batch. Your quality unit did not document details such as sample weight and preparation for tests such as (b)(4) content, (b)(4),(b)(4) or (b)(4) and(b)(4) content.
你们质量部门未能履行大量关键职责以确保USP规格的XX API粉依CGMP要求生产。例如,你们质量部门未能确保其所审核的记录包括所执行的所有检测生成的完整数据,以确保在API批次销售之前符合既定标准。你们质量部门并未记录详细信息如样品重量和检测用样品制备如XX含量、XX、XX或XX和XX含量。

Your quality unit also failed to ensure that samples intended for stability studies are stored with controlled temperature and humidity. Your firm kept retain and stability samples of (b)(4) USP in a cabinet in the quality control laboratory without monitoring temperature andrelative humidity.
你们的质量部门亦未能确保稳定性测试用样品存贮在受控的温湿度条件下。你们公司在QC化验室一个柜子里保存着XX USP的留样和稳定性样品,但并未监测温湿度。

In addition, your quality unit did not ensure the cleanliness of buildings and facilities used to manufacture API. You lacked sufficient controls to prevent the presence of pests in your packaging material storage area. At least twice, our inspector observed insects and spider webs in and on plastic-wrapped stacked containers used for packaging API.
此外,你们质量部门并未确保API生产所用建筑物和设施的清洁。你们缺乏足够的控制来防止在你们包装材料存贮区域出现昆虫。我们的检查人员至少有2次在塑料缠绕的堆叠API包装用容器内和上面发现昆虫和蜘蛛网。

Your quality unit also did not ensure that your cleaning validation records are accurate and contain appropriate documentation. For example, you did not document rinse times in your study to validate cleaning ofthe (b)(4) you use to manufacture API.
你们质量部门亦未确保你们清洁验证记录是准确的,并包括有适当的文件记录。例如,你们并未在你们的研究中记录淋洗次数以验证你们用于生产API的XX的清洁操作。

回复

使用道具 举报

药生
发表于 2018-8-15 10:26:59 | 显示全部楼层
来料不检测;过程不控制
回复

使用道具 举报

药徒
发表于 2018-8-15 11:14:20 | 显示全部楼层
2017年的才公布吗

点评

搬运过来,跟浦友们分享内容,呵呵呵,时间不重要,关键是我们身边有没有这样的情况,资源共享........................................................  详情 回复 发表于 2018-8-15 11:27
回复

使用道具 举报

药士
 楼主| 发表于 2018-8-15 11:27:50 | 显示全部楼层

搬运过来,跟浦友们分享内容,呵呵呵,时间不重要,关键是我们身边有没有这样的情况,资源共享........................................................
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

×发帖声明
1、本站为技术交流论坛,发帖的内容具有互动属性。您在本站发布的内容:
①在无人回复的情况下,可以通过自助删帖功能随时删除(自助删帖功能关闭期间,可以联系管理员微信:8542508 处理。)
②在有人回复和讨论的情况下,主题帖和回复内容已构成一个不可分割的整体,您将不能直接删除该帖。
2、禁止发布任何涉政、涉黄赌毒及其他违反国家相关法律、法规、及本站版规的内容,详情请参阅《蒲公英论坛总版规》。
3、您在本站发表、转载的任何作品仅代表您个人观点,不代表本站观点。不要盗用有版权要求的作品,转贴请注明来源,否则文责自负。
4、请认真阅读上述条款,您发帖即代表接受上述条款。

QQ|手机版|蒲公英|ouryao|蒲公英 ( 京ICP备14042168号-1 )  增值电信业务经营许可证编号:京B2-20243455  互联网药品信息服务资格证书编号:(京)-非经营性-2024-0033

GMT+8, 2025-4-23 15:23

Powered by Discuz! X3.4运维单位:苏州豚鼠科技有限公司

Copyright © 2001-2020, Tencent Cloud.

声明:蒲公英网站所涉及的原创文章、文字内容、视频图片及首发资料,版权归作者及蒲公英网站所有,转载要在显著位置标明来源“蒲公英”;禁止任何形式的商业用途。违反上述声明的,本站及作者将追究法律责任。
快速回复 返回顶部 返回列表